TAE Life Sciences

taelifesciences.com

TAE Life Sciences is developing a novel biological-targeting radiation therapy based on Boron Neutron Capture Therapy (BNCT) to improve the lives of patients with rapidly spreading, invasive and recurrent cancers that do not respond to other cancer therapies. TLS is the only company with a comprehensive target drug and neutron technology product portfolio to enable next-generation combination cancer therapy as a first-line treatment for patients globally.